Helus Pharma Inc. (HELP) stock forecast and price target
Price $8.87 · data as of November 13, 2026
12-month price target
Average target$40.61
Upside / downside+357.8%
Analysts10
ConsensusStrong buy
Low $14.85Average $40.61High $68.93
Gold marker: average target · white marker: today’s price ($8.87)
Analyst ratings
Strong buy 1Buy 10Hold 0Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends March 31, 2027 | $-4.10 | +30.6% | $0 |
| Next fiscal year ends March 31, 2028 | $-2.47 | +39.8% | $14M |
| Next quarter ends December 31, 2026 | $-0.95 | +30.5% | $0 |
| Quarter after ends March 31, 2027 | $-0.98 | +18.4% | $0 |
Consensus of the analysts covering Helus Pharma, updated daily. In the last 30 days 0 estimates were raised and 2 lowered.
Frequently asked questions
What is the Helus Pharma stock price target?
The average 12-month target from 10 analysts is $40.61, 357.8% above the current price of $8.87 Targets range from $14.85 to $68.93.
Is Helus Pharma a buy according to analysts?
The consensus rating is “Strong buy” (1 strong buy, 10 buy). Ratings are opinions, not guarantees; this is not investment advice.
How much is Helus Pharma expected to earn?
Analysts expect EPS of $-4.10 for the fiscal year ending March 31, 2027 and $-2.47 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.